The Kimberling Usher Research Laboratory in the Institute for Vision Research is pleased to announce an increase in our campaign goal to $10 million.
July 13th, 2018
January 31st, 2018
The University of Iowa has decided to return the name of our institute to The University of Iowa Institute for Vision Research.
You can read the full text of the University’s press release here.
December 27th, 2017
The pharmaceutical company Spark Therapeutics recently announced FDA approval1,2 of a gene therapy known as Luxturna, which has been shown to improve vision in patients with an extremely rare inherited eye disease caused by mutations in the gene RPE65.